 |
|
|
 |
|
Parkinson's Drugs Can Damage Heart Valves
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 | 3 In a related story, a new drug to treat early Parkinson's, called transdermal rotigotine, has shown in a phase 3 clinical trial that it is safe and effective, according to a report in Neurology.
Rotigotine is a non-ergot-derived dopamine receptor agonist delivered via a patch designed for once-a-day application. The drug is currently being reviewed by the FDA. It is currently marketed in Europe as therapy for early-stage Parkinson's and has received a favorable review for advanced-stage Parkinson's, according to the German drug company Schwarz Pharma, the maker of rotigotine.
More information
Text Continues Below

There's more on Parkinson's disease at the U.S. National Institute of Neurological Disorders and Stroke.
Page: << Prev | 1 | 2 | 3
|
Copyright © 2007 ScoutNews, LLC. All rights reserved.
Last updated 1/3/2007
|
 |

SOURCES: Bryan L. Roth, M.D., Ph.D., professor, department of pharmacology, University of North Carolina, Chapel Hill, Medical School; Jan. 4, 2007, New England Journal of Medicine; Jan 3, 2007, Schwarz Pharma, news release
|